Blue Star Q2 results: net profit rises 25.2% to Rs 123.92 crore

Blue Star Limited reported consolidated net profit attributable to its owners of Rs 123.92 crore for the quarter ended 30 September 2026, up 25.2% from Rs 99.01 crore a year earlier, according to its filing with the National Stock Exchange. Revenue from operations was Rs 2,930.95 crore. The board approved the unaudited results on 29 October 2026.

What Happened

The company said in the filing that its board approved the unaudited standalone and consolidated results for the second quarter and half year ended 30 September 2026, along with the limited review reports. The figures below are consolidated.

Revenue from operations was Rs 2,930.95 crore. That is 21.0% higher than the Rs 2,422.37 crore in the same quarter a year earlier. It is 13.2% lower than the Rs 3,377.92 crore in the previous quarter, April to June 2026.

Profit for the period attributable to owners was Rs 123.92 crore. That compares with Rs 99.01 crore a year earlier, a rise of 25.2%, and Rs 102.50 crore in the previous quarter, a rise of 20.9%. Basic earnings per share were Rs 6.03, against Rs 4.80 a year earlier.

The latest quarter includes an exceptional item. The notes to the results say the group recognised an exceptional gain of Rs 23.02 crore from the sale of the Medtech business by Blue Star Engineering & Electronics Limited, a wholly owned subsidiary. Before exceptional items and tax, the quarter's profit was Rs 134.28 crore, against Rs 132.17 crore a year earlier. The notes also record a profit of Rs 9.17 crore on a property sale, which the table places in the previous quarter. Together the two items make up the exceptional income of Rs 32.19 crore for the half year.

For the half year, revenue from operations was Rs 6,308.87 crore and profit attributable to owners was Rs 226.42 crore, against Rs 219.97 crore a year earlier.

What It Means

The filing shows higher revenue and profit than the same quarter last year. Revenue was lower than in the previous quarter, which the table reports without comment.

Part of the quarter's profit comes from the one-time gain on the Medtech sale, which the company reports separately from its regular operations. Readers who want the full statements, segment results and auditor's report can read the company's filing on the National Stock Exchange website.

This report states what the company disclosed. It is not investment advice.

Source: Company filing on NSE